Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjögren's syndrome using conventional immunological approaches

Rheumatology

Volumn 43, Issue 12, 2004, Pages 1488-1495

  Dawson, L J ^a   Allison, H E ^a   Stanbury, J ^a   Fitzgerald, D ^a   Smith, P M ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Anti muscarinic M3 antibodies; Calcium; Human salivary acinar cells; Sj gren's syndrome

Indexed keywords

AUTOANTIBODY; CALCIUM; EPITOPE; IMMUNOGLOBULIN G; MUSCARINIC M3 RECEPTOR; PROTEIN G;

ACINAR CELL; ADULT; AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CALCIUM CELL LEVEL; CHO CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MICROFLUOROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SALIVARY GLAND; SJOEGREN SYNDROME; WESTERN BLOTTING;

ANIMALS; AUTOANTIBODIES; BIOLOGICAL ASSAY; BLOTTING, WESTERN; CALCIUM; CHO CELLS; CRICETINAE; CRICETULUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MICE; RECEPTOR, MUSCARINIC M3; SJOGREN'S SYNDROME; SUBMANDIBULAR GLAND; TRANSFECTION;

EID: 10444274947     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh389     Document Type: Article

References (37)

1. Fox RI, Maruyama T. Pathogenesis and treatment of Sjogren's syndrome. Curr Opin Rheumatol 1997;9:393-9.
2. Humphreys-Beher MG, Brayer J, Yamachika S, Peck AB, Jonsson R. An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression. Scand J Immunol 1999;49:7-10.
3. Dawson LJ, Smith PM, Moots RJ, Field EA. Sjögren's syndrome - time for a new approach. Rheumatology 2000;39:234-7.
4. Dawson LJ, Field EA, Harmer AR, Smith PM. Acetylcholine-evoked calcium mobilization and ion channel activation in human labial gland acinar cells from patients with primary Sjogren's syndrome. Clin Exp Immunol 2001;124:480-5.
5. Pedersen AM, Dissing S, Fahrenkrug J, Hannibal J, Reibel J, Nauntofte B. Innervation pattern and Ca2+ signalling in labial salivary glands of healthy individuals and patients with primary Sjogren's syndrome (pSS). J Oral Pathol Med 2000;29:97-109.
6. Smith PM. Mechanisms of secretion by salivary glands. In: Edgar WM, O'Mullane D (eds) Saliva and Oral Health. London: British Dental Association, 1996:9-25.
7. Matsui M, Motomura D, Karasawa H et al. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA 2000;97:9579-84.
8. Bacman SR, Berra A, Sterin-Borda L, Borda ES. Human primary Sjogren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors. Curr Eye Res 1998;17:1135-42.
9. Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren's syndrome. Invest Ophthalmol Vis Sci 1998;39:151-6.
10. Bacman S, Sterin-Borda L, Camusso JJ, Arana R, Hubscher O, Borda E. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren's syndrome. Clin Exp Immunol 1996;104:454-9.
11. Robinson CP, Brayer J, Yamachika S et al. Transfer of human serum IgG to nonobese diabetic Igμ null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome. Proc Natl Acad Sci USA 1998;95:7538-43.
12. Bacman S, Berra A, Sterin-Borda L, Borda E. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndrome. Invest Ophthalmol Vis Sci 2001;42:321-7.
13. Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum 2000;43:1647-54.
14. Goldblatt F, Gordon TP, Waterman SA. Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 2002;123: 1144-50.
15. Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda ES. Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjogren syndrome antibodies. Clin Immunol 1999;90:190-5.
16. Ehlert FJ. The interaction of 4-DAMP mustard with subtypes of the muscarinic receptor. Life Sci 1996;58:1971-8.
17. Hulme EC, Birdsall NJ, Buckley NJ. Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 1990;30:633-73.
18. Watson EL, Abel PW, DiJulio D et al. Identification of muscarinic receptor subtypes in mouse parotid gland. Am J Physiol 1996;271:C905-C913.
19. Wang HY, Zeng SJ, Qiu PX. Development of muscarinic m3 and m4 receptor antibodies with pharmacological activities. Zhongguo Yao Li Xue Bao 1998;19:523-6.
20. Buckley NJ, Bonner TI, Buckley CM, Brann MR. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 1989;35:469-76.
21. Tobin AB, Nahorski SR. Rapid agonist-mediated phosphorylation of m3-muscarinic receptors revealed by immunoprecipitation. J Biol Chem 1993;268:9817-23.
22. Smith PK, Krohn RI, Hermanson GT et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
23. Vitali C. Classification criteria for Sjogren's syndrome. Ann Rheum Dis 2003;62:94-5, author reply 95.
24. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
26. + and C1- currents in mouse submandibular cells. J Physiol 1992;449:109-20.
27. Hann LE, Kelleher RS, Sullivan DA. Influence of culture conditions on the androgen control of secretory component production by acinar cells from the rat lacrimal gland. Invest Ophthalmol Vis Sci 1991;32: 2610-21.
28. Dawson LJ, Christmas SE, Smith PM. An investigation of interactions between the immune system and stimulus- secretion coupling in mouse submandibular acinar cells. A possible mechanism to account for reduced salivary flow rates associated with the onset of Sjögren's syndrome. Rheumatology 2000;39:1226-33.
29. 2+ concentration by acetylcholine in acutely isolated mouse submandibular acinar cells. Biochem J 1996; 317:779-83.
30. Weetman AP. Graves' disease. N Engl J Med 2000;343:1236-48.
31. Chazenbalk GD, Wang Y, Guo J et al. A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies. J Clin Endocrinol Metab 1999;84:702-10.
32. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330:1797-810.
33. Cavill D, Waterman SA, Gordon TP. Failure to detect antibodies to extracellular loop peptides of the musearinic M3 receptor in primary Sjogren's syndrome. J Rheumatol 2002;29:1342-4.
34. Bonner TI, Buckley NJ, Young AC, Brann MR. Identification of a family of muscarinic acetylcholine receptor genes. Science 1987; 237:527-32.
35. Vitti P, Elisei R, Tonacchera M et al. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor. J Clin Endocrinol Metab 1993; 76:499-503.
36. Gordon TP, Bolstad AI, Rischmueller M, Jonsson R, Waterman SA. Autoantibodies in primary Sjogren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity 2001;34:123-32.
37. Fox PC, Speight PM. Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjogren's syndrome. Crit Rev Oral Biol Med 1996;7:144-58.